Femme Homme
- | Pays :
- Japan
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to assess the tolerability of 500mg fulvestrant in postmenopausal women with hormone receptor positive, advanced or recurrent breast cancer
Critère d'inclusion
- Advanced breast cancer